Niagen Bioscience (NAGE) Assets Average (2011 - 2026)

Niagen Bioscience (NAGE) has 14 years of Assets Average data on file, last reported at $110.4 million in Q1 2026.

• On a quarterly basis, Assets Average rose 47.54% year-over-year to $110.4 million in Q1 2026; TTM through Mar 2026 was $110.4 million, a 47.54% increase from a year earlier, with the FY2025 full-year figure at $87.3 million, up 41.74% from the prior year.
• Assets Average for Q1 2026 stood at $110.4 million, up from $102.3 million in the prior quarter.
• Over the last five years, Assets Average for NAGE reached as high as $110.4 million in Q1 2026 and fell as low as $46.1 million in Q3 2022.
• Historically, Assets Average has averaged $65.4 million across 5 years, with a median of $54.5 million in 2024.
• Across the five-year window, Assets Average retreated 26.93% in 2022 and soared 71.55% in 2025, its largest moves.
• Year by year, Assets Average stood at $49.9 million in 2022, then increased by 8.75% to $54.2 million in 2023, then grew by 15.08% to $62.4 million in 2024, then soared by 63.9% to $102.3 million in 2025, then rose by 7.92% to $110.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $110.4 million in Q1 2026, $102.3 million in Q4 2025, and $94.8 million in Q3 2025.